论文部分内容阅读
自2009年卫生部分布“关于建立国家基本药物制度的实施意见”以来,我国基本药物制度从遴选、生产、流通、使用、定价、报销及监测评价等方面逐渐走向正式轨道。本文探讨了基本药物制度建立以来,从基本药物的不良反应监测成效上,分别就其基础状况、监测评价、风险控制等问题进行梳理,并就近年来基本药物的风险管理特点进行归纳,最后从加强基本药品不良反应监测机构建设上,探索积极的监测方法,来深化医改工作的可持续发展。
Since the Ministry of Health issued the Opinions on Establishing the National Essential Drugs System in 2009, the basic drug system in our country has gradually shifted to the official track from the aspects of selection, production, circulation, use, pricing, reimbursement and monitoring and evaluation. This article explores the basic drug system since the establishment of basic drugs from the side effects of adverse reactions monitoring, respectively, on its basic conditions, monitoring and evaluation, risk control and other issues to sort out and summarize the characteristics of risk management of essential drugs in recent years, and finally from strengthening On the construction of institutions for the monitoring of adverse reactions of essential drugs, we should explore positive monitoring methods to deepen the sustainable development of medical reform work.